Adam Epstein is an experienced executive in the medical device and healthcare sectors, currently serving as the Chief Executive Officer at AliMed since December 2019. In this role, Adam oversees the company’s operations and product portfolio, aimed at enhancing care for patients. Adam's leadership previously included positions as Chief Technology Officer at UFP Technologies and Dielectrics, Inc., where significant advancements in product innovation and market strategy were achieved. Adam also has experience as a Product Manager at Synthes, where new product lines were successfully launched. Additionally, Adam is a member of Vistage Worldwide, Inc., a peer advisory organization for CEOs. Adam's educational background includes studies at the Isenberg School of Management at UMass Amherst, The Philipp University of Marburg, and the University of Rochester.